RT @DrCassySims: How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a differen

Tweet Author

Tweet Content

How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a difference? @RheumNow #ACR22 https://t.co/2oJ1RAeciN https://t.co/c9s6QRSOR4

Links

Impact of COVID 19 on Pregnancies in Women with RMD - YouTube https://youtu.be/EoKO_VgrU-A

RT @RichardPAConway: Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow

Tweet Author

RichardPAConway

Tweet Content

Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow #ACR22 Abstr#2251 #ACRbest https://t.co/R5rQ3KcHnq https://t.co/8Nq0t4zqQK

Links

Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in … https://acrabstracts.org/abstract/reduction-in-rheumatoid-arthritis-associated-…

RT @Janetbirdope: #Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, les

Tweet Author

Janetbirdope

Tweet Content

#Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, less infections if 600 mg IV fixed q6 mo how long to continue? Abst#1084 and less flares w Rituximab maintenance in the MAINRITSAN studies abst#527 Ritux is new SoC in GPA @RheumNow

RT @RichardPAConway: Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in

Tweet Author

RichardPAConway

Tweet Content

Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in CDASI (both activity and damage) and SF-36. @RheumNow #ACR22 Abstr#2239 https://t.co/vsnvYUla13

Links

Effect of Treatment with IVIG (octagam10%) on Skin Symptoms and Quality of Life… https://acrabstracts.org/abstract/effect-of-treatment-with-ivig-octagam10-on-sk…

RT @RHEUMarampa: Let's review how GCs induce #Osteoporosis ð(every Rheum should know this!) ðGCs have bone cell sp

Tweet Author

RHEUMarampa

Tweet Content

Let's review how GCs induce #Osteoporosis 👇(every Rheum should know this!) 💊GCs have bone cell specific effects on: 💠Osteoclasts ⬆️resorption, survival 💠Osteoblasts ⬇️🦴formation & prolif; ⬆️apoptosis 💠Osteocytes ⬆️apoptosis & skeletal fragility #ACR22 @RheumNow @rheumarhyme https://t.co/n61OXkmRgr

RT @RichardPAConway: Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>s

Tweet Author

RichardPAConway

Tweet Content

Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>seronegative>other abs @RheumNow #ACR22 Abstr#2241 https://t.co/g8xTRyw6NZ https://t.co/sR1tT2QmU3

Links

Autoantibodies and Damage in Patients with Idiopathic Inflammatory Myopathies: … https://acrabstracts.org/abstract/autoantibodies-and-damage-in-patients-with-id…

RT @uptoTate: BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half

Tweet Author

uptoTate

Tweet Content

BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half of pts w/ active PsA who are bDMARD-naïve or TNFi-IR. Abs 2119 #ACR22 @RheumNow https://t.co/29gzmMZRlG https://t.co/qziqGNxQih

Links

Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic D… http://ow.ly/EM3q50LAlKT

RT @uptoTate: After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further stu

Tweet Author

uptoTate

Tweet Content

After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further studies needed to perform survival subgroup analysis regarding different extra-articular manifestations and PsA subtypes. Abs 2149 #ACR22 @RheumNow https://t.co/SRPhSiGeUI https://t.co/EYDULe52A3

Links

Cycling versus Swapping Strategies in Psoriatic Arthritis: Results from the Rhe… http://ow.ly/Lriw50LAjPo

RT @RichardPAConway: Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @Rhe

Tweet Author

RichardPAConway

Tweet Content

Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @RheumNow #ACR22 Abstr#2252 https://t.co/woVErubytC https://t.co/r916r1AxtN

Links

Higher Matrix Metalloproteinase Levels Are Predictive of Incident Interstitial … https://acrabstracts.org/abstract/higher-matrix-metalloproteinase-levels-are-pr…

RT @uptoTate: More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow htt

Tweet Author

uptoTate

Tweet Content

More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow https://t.co/OrrDWfvGty https://t.co/CdCQzmgOOO

Links

Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in a Phase 2 T… http://ow.ly/FAjC50LAlz5

Topics

RT @DrCassySims: How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a differen

RT @RichardPAConway: Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow

RT @Janetbirdope: #Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, les

RT @RichardPAConway: Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in

RT @RHEUMarampa: Let's review how GCs induce #Osteoporosis ð(every Rheum should know this!) ðGCs have bone cell sp

RT @RichardPAConway: Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>s

RT @uptoTate: BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half

RT @uptoTate: After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further stu

RT @RichardPAConway: Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @Rhe

RT @uptoTate: More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow htt

Do you get our email newsletter?

RT @DrCassySims: How does #COVID19 impact pregnant women with rheumatic disease? Does vaccination status make a differen

RT @RichardPAConway: Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow

RT @Janetbirdope: #Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, les

RT @RichardPAConway: Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in

RT @RHEUMarampa: Let's review how GCs induce #Osteoporosis ð(every Rheum should know this!) ðGCs have bone cell sp

RT @RichardPAConway: Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl&gt;s

RT @uptoTate: BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half

RT @uptoTate: After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further stu

RT @RichardPAConway: Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @Rhe

RT @uptoTate: More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow htt

RT @RHEUMarampa: Let's review how GCs induce #Osteoporosis ð(every Rheum should know this!) ðGCs have bone cell sp

RT @RichardPAConway: Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>s